Gabelli Funds LLC Sells 2,500 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Gabelli Funds LLC trimmed its stake in shares of ICU Medical, Inc. (NASDAQ:ICUIFree Report) by 3.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 69,550 shares of the medical instruments supplier’s stock after selling 2,500 shares during the quarter. Gabelli Funds LLC owned approximately 0.29% of ICU Medical worth $6,937,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. CWM LLC lifted its holdings in ICU Medical by 341.2% in the fourth quarter. CWM LLC now owns 578 shares of the medical instruments supplier’s stock worth $58,000 after buying an additional 447 shares during the period. Quadrant Capital Group LLC boosted its holdings in ICU Medical by 681.6% in the fourth quarter. Quadrant Capital Group LLC now owns 594 shares of the medical instruments supplier’s stock worth $59,000 after acquiring an additional 518 shares in the last quarter. SG Americas Securities LLC purchased a new stake in shares of ICU Medical in the fourth quarter worth $106,000. Private Trust Co. NA raised its position in shares of ICU Medical by 273.8% in the 4th quarter. Private Trust Co. NA now owns 1,200 shares of the medical instruments supplier’s stock worth $120,000 after purchasing an additional 879 shares during the last quarter. Finally, PNC Financial Services Group Inc. grew its position in ICU Medical by 7.8% during the 4th quarter. PNC Financial Services Group Inc. now owns 2,576 shares of the medical instruments supplier’s stock valued at $257,000 after purchasing an additional 187 shares during the last quarter. Institutional investors own 96.10% of the company’s stock.

ICU Medical Price Performance

Shares of NASDAQ:ICUI opened at $112.17 on Friday. ICU Medical, Inc. has a 52-week low of $78.28 and a 52-week high of $196.57. The company has a debt-to-equity ratio of 0.76, a current ratio of 2.61 and a quick ratio of 1.09. The stock’s 50-day simple moving average is $101.96 and its two-hundred day simple moving average is $98.72.

ICU Medical (NASDAQ:ICUIGet Free Report) last issued its quarterly earnings results on Tuesday, May 7th. The medical instruments supplier reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.06. The business had revenue of $566.66 million for the quarter, compared to analysts’ expectations of $553.15 million. ICU Medical had a negative net margin of 2.63% and a positive return on equity of 5.38%. As a group, equities analysts forecast that ICU Medical, Inc. will post 3.5 earnings per share for the current year.

Insider Activity

In related news, Director Elisha W. Finney sold 300 shares of the firm’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $104.95, for a total transaction of $31,485.00. Following the completion of the transaction, the director now directly owns 2,129 shares of the company’s stock, valued at $223,438.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, Director Elisha W. Finney sold 300 shares of the firm’s stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $104.95, for a total value of $31,485.00. Following the completion of the sale, the director now directly owns 2,129 shares in the company, valued at $223,438.55. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director George A. Lopez sold 1,890 shares of the business’s stock in a transaction on Monday, March 11th. The shares were sold at an average price of $104.22, for a total value of $196,975.80. Following the transaction, the director now owns 317,753 shares of the company’s stock, valued at approximately $33,116,217.66. The disclosure for this sale can be found here. Insiders have sold 25,498 shares of company stock worth $2,633,440 in the last three months. Company insiders own 6.70% of the company’s stock.

Wall Street Analyst Weigh In

Separately, KeyCorp upped their price target on ICU Medical from $134.00 to $136.00 and gave the company an “overweight” rating in a report on Wednesday, February 28th.

Get Our Latest Report on ICU Medical

About ICU Medical

(Free Report)

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

Featured Articles

Institutional Ownership by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.